|
1
|
Kikuchi S, Hata M, Fukumoto K, Yamane Y,
Matsui T, Tamura A, Yonemura S, Yamagishi H, Keppler D and Tsukita
S and Tsukita S: Radixin deficiency causes conjugated
hyperbilirubinemia with loss of Mrp2 from bile canalicular
membranes. Nat Genet. 31:320–325. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sekine S, Ito K, Saeki J and Horie T:
Interaction of Mrp2 with radixin causes reversible canalicular Mrp2
localization induced by intracellular redox status. Biochim Biophys
Acta. 1812:1427–1434. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chai J, Cai SY, Liu X, Lian W, Chen S,
Zhang L, Feng X, Cheng Y, He X, He Y, et al: Canalicular membrane
MRP2/ABCC2 internalization is determined by Ezrin Thr567
phosphorylation in human obstructive cholestasis. J Hepatol.
63:1440–1448. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang Y, Dong J, Zhu X, Wang W and Yang Q:
The effect of sphingomyelin synthase 2 (SMS2) deficiency on the
expression of drug transporters in mouse brain. Biochem Pharmacol.
82:287–294. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kobori T, Fujiwara S, Miyagi K, Harada S,
Nakamoto K, Nakagawa T, Takahashi H, Narita M and Tokuyama S:
Involvement of moesin in the development of morphine analgesic
tolerance through P-glycoprotein at the blood-brain barrier. Drug
Metab Pharmacokinet. 29:482–489. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Matsui T, Maeda M, Doi Y, Yonemura S,
Amano M, Kaibuchi K and Tsukita S and Tsukita S: Rho-kinase
phosphorylates COOH-terminal threonines of ezrin/radixin/moesin
(ERM) proteins and regulates their head-to-tail association. J Cell
Biol. 140:647–657. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yano K, Shimizu S, Tomono T and Ogihara T:
Gastrointestinal hormone cholecystokinin increases P-glycoprotein
membrane localization and transport activity in Caco-2 cells. J
Pharm Sci. 106:2650–2656. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vaquero J, Nguyen Ho-Bouldoires TH,
Clapéron A and Fouassier L: Role of the PDZ-scaffold protein
NHERF1/EBP50 in cancer biology: From signaling regulation to
clinical relevance. Oncogene. 36:3067–3079. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He XJ, Wang WR, Zhang Y and Yang Q: The
effect of radixin knockdown on the expression and efflux function
of MRP2 in SGC-7901 cells. Eur J Pharm Sci. 46:426–434. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang L, Xiao R, Xiong J, Leng J, Ehtisham
A, Hu Y, Ding Q, Xu H, Liu S, Wang J, et al: Activated ERM protein
plays a critical role in drug resistance of MOLT4 cells induced by
CCL25. PLoS One. 8:e523842013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yano K, Otsuka K, Kato Y, Kawabata H,
Ohmori S, Arakawa H and Ogihara T: Different regulation of
P-glycoprotein function between Caco-2 and Caki-1 cells by ezrin,
radixin and moesin proteins. J Pharm Pharmacol. 68:361–367. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kawase A, Araki Y, Ueda Y, Nakazaki S and
Iwaki M: Impact of a high-cholesterol diet on expression levels of
Niemann-Pick C1-like 1 and intestinal transporters in rats and
mice. Eur J Drug Metab Pharmacokinet. 41:457–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kawase A, Sakata M, Yada N, Nakasaka M,
Shimizu T, Kato Y and Iwaki M: Decreased radixin function for
ATP-binding cassette transporters in liver in adjuvant-induced
arthritis rats. J Pharm Sci. 103:4058–4065. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
den Boer E, Meesters RJ, van Zelst BD,
Luider TM, Hazes JM, Heil SG and de Jonge R: Measuring methotrexate
polyglutamates in red blood cells: A new LC-MS/MS-based method.
Anal Bioanal Chem. 405:1673–1681. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Uchida Y, Ohtsuki S, Kamiie J, Ohmine K,
Iwase R and Terasaki T: Quantitative targeted absolute proteomics
for 28 human transporters in plasma membrane of Caco-2 cell
monolayer cultured for 2, 3, and 4 weeks. Drug Metab Pharmacokinet.
30:205–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Prasad B and Unadkat JD: Optimized
approaches for quantification of drug transporters in tissues and
cells by MRM proteomics. AAPS J. 16:634–48. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Harwood MD, Achour B, Russell MR, Carlson
GL, Warhurst G and Rostami-Hodjegan A: Application of an LC-MS/MS
method for the simultaneous quantification of human intestinal
transporter proteins absolute abundance using a QconCAT technique.
J Pharm Biomed Anal. 110:27–33. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kawase A, Fujii A, Negoro M, Akai R,
Ishikubo M, Komura H and Iwaki M: Differences in cytochrome P450
and nuclear receptor mRNA levels in liver and small intestines
between SD and DA rats. Drug Metab Pharmacokinet. 23:196–206. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kawase A, Yamada A, Gamou Y, Tahara C,
Takeshita F, Murata K, Matsuda H, Samukawa K and Iwaki M: Increased
effects of ginsenosides on the expression of cholesterol
7α-hydroxylase but not the bile salt export pump are involved in
cholesterol metabolism. J Nat Med. 67:545–553. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–8. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Puaux AL, Ong LC, Jin Y, Teh I, Hong M,
Chow PK, Golay X and Abastado JP: A comparison of imaging
techniques to monitor tumor growth and cancer progression in living
animals. Int J Mol Imaging. 2011:3215382011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yano K, Tomono T, Sakai R, Kano T,
Morimoto K, Kato Y and Ogihara T: Contribution of radixin to
P-glycoprotein expression and transport activity in mouse small
intestine in vivo. J Pharm Sci. 102:2875–2881. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nakano T, Sekine S, Ito K and Horie T:
Correlation between apical localization of Abcc2/Mrp2 and
phosphorylation status of ezrin in rat intestine. Drug Metab
Dispos. 37:1521–1527. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pokharel D, Padula M, Lu J, Jaiswal R,
Djordjevic S and Bebawy M: The role of CD44 and ERM proteins in
expression and functionality of P-glycoprotein in breast cancer
cells. Molecules. 21:2902016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kano T, Wada S, Morimoto K, Kato Y and
Ogihara T: Effect of knockdown of ezrin, radixin, and moesin on
P-glycoprotein function in HepG2 cells. J Pharm Sci. 100:5308–5314.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kool M, van der Linden M, de Haas M,
Scheffer GL, de Vree JM, Smith AJ, Jansen G, Peters GJ, Ponne N,
Scheper RJ, et al: MRP3, an organic anion transporter able to
transport anti-cancer drugs. Proc Natl Acad Sci USA. 96:6914–6919.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hooijberg JH, Broxterman HJ, Kool M,
Assaraf YG, Peters GJ, Noordhuis P, Scheper RJ, Borst P, Pinedo HM
and Jansen G: Antifolate resistance mediated by the multidrug
resistance proteins MRP1 and MRP2. Cancer Res. 59:2532–2535.
1999.PubMed/NCBI
|
|
28
|
Zeng H, Chen ZS, Belinsky MG, Rea PA and
Kruh GD: Transport of methotrexate (MTX) and folates by multidrug
resistance protein (MRP)3 and MRP1: Effect of polyglutamylation on
MTX transport. Cancer Res. 61:7225–7232. 2001.PubMed/NCBI
|
|
29
|
Volk EL and Schneider E: Wild-type breast
cancer resistance protein (BCRP/ABCG2) is a methotrexate
polyglutamate transporter. Cancer Res. 63:5538–5543.
2003.PubMed/NCBI
|
|
30
|
Chen ZS, Robey RW, Belinsky MG,
Shchaveleva I, Ren XQ, Sugimoto Y, Ross DD, Bates SE and Kruh GD:
Transport of methotrexate, methotrexate polyglutamates, and
17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: Effects of
acquired mutations at R482 on methotrexate transport. Cancer Res.
63:4048–4054. 2003.PubMed/NCBI
|
|
31
|
Vlaming ML, van Esch A, van de Steeg E,
Pala Z, Wagenaar E, van Tellingen O and Schinkel AH: Impact of
abcc2 [multidrug resistance-associated protein (Mrp) 2], abcc3
(Mrp3), and abcg2 (breast cancer resistance protein) on the oral
pharmacokinetics of methotrexate and its main metabolite
7-hydroxymethotrexate. Drug Metab Dispos. 39:1338–1344. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nakase Y, Hagiwara A, Kin S, Fukuda K, Ito
T, Takagi T, Fujiyama J, Sakakura C, Otsuji E and Yamagishi H:
Intratumoral administration of methotrexate bound to activated
carbon particles: Antitumor effectiveness against human colon
carcinoma xenografts and acute toxicity in mice. J Pharmacol Exp
Ther. 311:382–387. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Choi CH: ABC transporters as multidrug
resistance mechanisms and the development of chemosensitizers for
their reversal. Cancer Cell Int. 5:302005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chien AJ and Moasser MM: Cellular
mechanisms of resistance to anthracyclines and taxanes in cancer:
Intrinsic and acquired. Semin Oncol. 35 (Suppl 2):S1–S14; quiz S39.
2008. View Article : Google Scholar : PubMed/NCBI
|
